CIK 0001211583
- Non-accelerated filer
- Smaller reporting company
FENNEC PHARMACEUTICALS INC.
Sign in to watch- Ticker
- FENC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 919-636-4530
- Business address
- PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Former names
- ADHEREX TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,550,718
- in 5 filings, $1.4M under 10b5-1 plans
Net −$1,550,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 7 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-30 | Andrade Robert CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −7,500 | $8.82 | $66K | 124,721 |
| 2023-06-29 | Andrade Robert CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −7,500 | $8.97 | $67K | 132,221 |
| 2023-06-28 | Andrade Robert CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −10,000 | $8.99 | $90K | 139,721 |
| 2023-05-19 | RALLIS CHRIS A Director | Sale 10b5-1 | −833 | $7.36 | $6K | 31,958 |
| 2023-05-19 | RALLIS CHRIS A Director | Sale 10b5-1 | −925 | $7.36 | $7K | 31,033 |
| 2022-12-30 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Sale | −1,600 | $9.66 | $15K | 226,238 |
| 2022-12-30 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Sale | −8,400 | $9.61 | $81K | 217,838 |
| 2022-12-30 | Andrade Robert CHIEF FINANCIAL OFFICER | Sale | −5,500 | $9.61 | $53K | 149,721 |
| 2022-12-29 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Sale | −5,000 | $9.65 | $48K | 227,838 |
| 2022-12-29 | Andrade Robert CHIEF FINANCIAL OFFICER | Sale | −5,500 | $9.57 | $53K | 155,221 |
| 2022-12-28 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Sale | −13,740 | $9.59 | $132K | 232,838 |
| 2022-12-28 | Andrade Robert CHIEF FINANCIAL OFFICER | Sale | −11,000 | $9.61 | $106K | 160,721 |
| 2022-11-17 | RALLIS CHRIS A Director | Sale | −333 | $7.99 | $3K | 30,018 |
| 2018-03-28 | MANCHESTER MANAGEMENT PR, LLC 10% owner | Sale | −605 | $11.65 | $7K | 1,812,454 |
| 2018-03-28 | MANCHESTER MANAGEMENT PR, LLC 10% owner | Sale | −605 | $11.65 | $7K | 1,395,788 |
| 2018-03-28 | MANCHESTER MANAGEMENT PR, LLC 10% owner | Sale | −145,788 | $11.50 | $1.7M | 1,666,666 |
| 2018-03-28 | MANCHESTER MANAGEMENT PR, LLC 10% owner | Sale | −145,788 | $11.50 | $1.7M | 1,250,000 |
| 2018-03-27 | MANCHESTER MANAGEMENT PR, LLC 10% owner | Sale | −22,707 | $11.34 | $257K | 1,813,059 |
| 2018-03-27 | MANCHESTER MANAGEMENT PR, LLC 10% owner | Sale | −22,707 | $11.34 | $257K | 1,396,393 |
| 2018-03-23 | MANCHESTER MANAGEMENT PR, LLC 10% owner | Sale | −3,500 | $10.88 | $38K | 1,835,766 |
Page 5 of 7 · 125 trades